New York University

Inspirna, Inc.

Rgenix, Inc.

Foster Casimir Gonsalves

Ramanuj Dasgupta

Masoud Tavazoie

Isabel Kurth

David M Darst, Jr

Sohail Tavazoie

Eduardo J Martinez

Bernd Kaiser

Susan Katherine Logan

Eugine Lee

Benjamin N Ostendorf

Sohail F Tavazoie

Masoud Fakhr Tavazoie

The invention features methods of treating cancer with β-GPA. The disclosure also provides methods of treating cancer including combinations of β-GPA and additional anti-cancer therapies.

Methods of treating cancer

This invention features compounds that modulate the activity of liver X receptors, pharmaceutical compositions including the compounds of the invention, and methods of utilizing those compositions for modulating the activity of liver X receptors in the treatment of cancer.

LXR agonists and uses thereof

A novel method which integrates a 'sensitized' chemical genetic high-throughput screen (HTS) with RNA interference (RNAi) screening technology is described herein. The present inventors used this method to identify specific small molecule inhibitors and activators of the Wnt pathway. More particularly, the screening method of the present invention may be used to identify small molecule inhibitors and activators that specifically target the activity of a stabilized pool of &#x3b2;-catenin. A number of compounds identified using the instant method, are shown herein to be small molecule inhibitors of the Wnt pathway that specifically target the activity of the stabilized pool of &#x3b2;-cat. The inhibitors identified by the present method may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, cancer, and others.

Targeted chemical high-throughput screening method

A series of oxazole and thiazole compounds are shown herein to be small molecule inhibitors of the Wnt pathway that specifically target the activity of the stabilized pool of &#x3b2;-cat oxazole and thiazole compounds are disclosed that have a formula represented by the following:  The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, cancer, and others.

Oxazole and thiazole compounds as &#x3b2;-catenin modulators and uses thereof

A series of oxazole and thiazole compounds are shown herein to be small molecule inhibitors of the Wnt pathway that specifically target the activity of the stabilized pool of &#x3b2;-catenin. Oxazole and thiazole compounds are disclosed that have a formula represented by the following:  The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, cancer, and others.

Oxazole and thiazole compounds as beta-catenin modulators and uses thereof

A series of oxazole and thiazole compounds are shown herein to be small molecule inhibitors of the Wnt pathway that specifically target the activity of the stabilized pool of &#x3b2;-cat oxazole and thiazole compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, cancer, and others.

Growing community of inventors

Long Island City, NY, United States of America

Foster Casimir Gonsalves